Aristotle University Of Thessaloniki (AUTH)
Φαρμακοκινητική / φαρμακοδυναμική συσχέτιση της αμοξικιλλίνης στο πρόβατο
Abstract
dc:descriptionAmoxicillin (AMX), a semi-synthetic, broad-spectrum α-amino-p-hydroxybenzylpenicillin has been long used in veterinary medical practice for the treatment of bacterial respiratory, urinary, gastrointestinal, dermal, dental and other infections. In sheep therapeutics, AMX is typically administered intramuscularly as its trihydrate form, contained in conventional or long-acting formulations (suspensions). Although published pharmacokinetic studies of AMX in several animal species and humans generally describe a highly variable distribution in several body organs and tissues (i.e. good penetration in kidneys, liver, lungs, muscles, peritoneal, pleural and synovial fluids, etc. versus reduced penetration in the central nervous system, aqueous humour, lacrimal fluid, sweat, saliva and milk), no relevant data exist in sheep. A complete dearth of data is also observed concerning the influence of the formulation type and the injection site on AMX absorption and its pharmacokinetic behavior, after intramuscular administration. Antimicrobials of the β-lactam class are generally described as agents displaying a time-dependent bactericidal activity, the in vivo efficacy of which relies on the achieved value of the therapeutic time (T>MIC) index, defined as the time, expressed as a percentage of the 24 hours post administration, during which drug concentrations exceed the minimal inhibitory concentration (MIC) against the targeted bacterial pathogen. It has been proposed that maximization of AMX bactericidal effect also requires, on occasion, a rise of its levels up to 5 ? MIC; however, such an assumption is yet to be confirmed for pathogen microorganisms isolated from clinical cases in sheep. The present doctoral thesis has been conducted in order to study a) the pharmacokinetics and distribution of AMX in sheep, with use of the tissue cage model, after its intravenous and intramuscular administrations, b) its pharmacodynamics against pathogen microorganisms, responsible for causing severe infections in the specific animal species, and c) the correlation of pharmacokinetic and pharmacodynamic data for the evaluation of the drug’s therapeutic efficacy.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Delis, Georgios
- Δελής, Γεώργιος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19233